| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 39 | 2023 | 635 | 5.760 |
Why?
|
| Wrist Joint | 38 | 2022 | 59 | 5.060 |
Why?
|
| Arthroplasty, Replacement, Hip | 35 | 2019 | 810 | 3.900 |
Why?
|
| Ambulatory Surgical Procedures | 7 | 2019 | 75 | 2.580 |
Why?
|
| Ulna | 17 | 2022 | 29 | 2.370 |
Why?
|
| Postoperative Complications | 19 | 2021 | 911 | 2.150 |
Why?
|
| Ligaments, Articular | 16 | 2019 | 107 | 1.720 |
Why?
|
| Joint Diseases | 6 | 2016 | 111 | 1.690 |
Why?
|
| Joint Instability | 18 | 2015 | 385 | 1.680 |
Why?
|
| Knee Prosthesis | 14 | 2023 | 224 | 1.670 |
Why?
|
| Humans | 144 | 2023 | 26946 | 1.520 |
Why?
|
| Minimally Invasive Surgical Procedures | 15 | 2010 | 312 | 1.480 |
Why?
|
| Patient Discharge | 4 | 2019 | 158 | 1.470 |
Why?
|
| Arthroplasty, Replacement | 7 | 2022 | 151 | 1.370 |
Why?
|
| Middle Aged | 75 | 2022 | 8887 | 1.330 |
Why?
|
| Osteoarthritis, Knee | 9 | 2022 | 365 | 1.240 |
Why?
|
| Reoperation | 27 | 2023 | 921 | 1.210 |
Why?
|
| Range of Motion, Articular | 28 | 2022 | 698 | 1.210 |
Why?
|
| Adult | 60 | 2020 | 7793 | 1.180 |
Why?
|
| Male | 77 | 2021 | 14718 | 1.140 |
Why?
|
| Female | 76 | 2021 | 15166 | 1.080 |
Why?
|
| Wrist | 5 | 2021 | 16 | 1.020 |
Why?
|
| Knee Joint | 16 | 2023 | 734 | 1.020 |
Why?
|
| Orthopedic Procedures | 7 | 2011 | 298 | 1.020 |
Why?
|
| Aged | 60 | 2021 | 8979 | 1.000 |
Why?
|
| Wrist Injuries | 11 | 2019 | 17 | 0.980 |
Why?
|
| Retrospective Studies | 34 | 2023 | 3522 | 0.950 |
Why?
|
| Triangular Fibrocartilage | 6 | 2019 | 7 | 0.950 |
Why?
|
| Outpatients | 4 | 2019 | 61 | 0.940 |
Why?
|
| Perioperative Care | 3 | 2019 | 45 | 0.940 |
Why?
|
| Joint Prosthesis | 7 | 2022 | 86 | 0.910 |
Why?
|
| Forearm | 7 | 2010 | 19 | 0.900 |
Why?
|
| Treatment Outcome | 40 | 2023 | 3454 | 0.880 |
Why?
|
| Prosthesis-Related Infections | 4 | 2023 | 185 | 0.870 |
Why?
|
| Recovery of Function | 11 | 2019 | 289 | 0.830 |
Why?
|
| Prosthesis Failure | 19 | 2023 | 522 | 0.820 |
Why?
|
| Hip Prosthesis | 15 | 2019 | 538 | 0.810 |
Why?
|
| Arthritis, Infectious | 1 | 2023 | 51 | 0.790 |
Why?
|
| Patient Readmission | 3 | 2017 | 129 | 0.750 |
Why?
|
| Follow-Up Studies | 29 | 2021 | 1784 | 0.740 |
Why?
|
| Prosthesis Design | 18 | 2021 | 489 | 0.680 |
Why?
|
| Arthralgia | 7 | 2019 | 132 | 0.630 |
Why?
|
| Ganglion Cysts | 1 | 2018 | 7 | 0.620 |
Why?
|
| Aged, 80 and over | 30 | 2019 | 4771 | 0.610 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2018 | 1106 | 0.600 |
Why?
|
| Tibia | 10 | 2021 | 237 | 0.590 |
Why?
|
| Biomechanical Phenomena | 13 | 2015 | 627 | 0.580 |
Why?
|
| Internal Medicine | 3 | 2015 | 30 | 0.570 |
Why?
|
| Pain, Postoperative | 7 | 2013 | 315 | 0.560 |
Why?
|
| Tendons | 8 | 2011 | 214 | 0.550 |
Why?
|
| Patient Care Team | 3 | 2016 | 119 | 0.550 |
Why?
|
| Carpal Bones | 3 | 2021 | 8 | 0.530 |
Why?
|
| Hand | 3 | 2011 | 39 | 0.520 |
Why?
|
| Drug Discovery | 2 | 2015 | 15 | 0.520 |
Why?
|
| Clinical Protocols | 4 | 2016 | 57 | 0.510 |
Why?
|
| Prostatitis | 2 | 2006 | 3 | 0.510 |
Why?
|
| Femur | 8 | 2019 | 372 | 0.500 |
Why?
|
| Pelvic Pain | 2 | 2006 | 12 | 0.500 |
Why?
|
| Oomycetes | 1 | 2015 | 1 | 0.500 |
Why?
|
| Receptors, Steroid | 1 | 2015 | 1 | 0.500 |
Why?
|
| Education, Medical, Continuing | 5 | 2018 | 33 | 0.490 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2015 | 2 | 0.490 |
Why?
|
| Radiography | 15 | 2015 | 616 | 0.480 |
Why?
|
| Attitude of Health Personnel | 4 | 2018 | 145 | 0.470 |
Why?
|
| Pyrazoles | 1 | 2015 | 59 | 0.460 |
Why?
|
| Carpal Joints | 3 | 2009 | 5 | 0.460 |
Why?
|
| Patient Safety | 2 | 2014 | 39 | 0.450 |
Why?
|
| Air Travel | 1 | 2014 | 1 | 0.450 |
Why?
|
| Preoperative Care | 4 | 2013 | 117 | 0.440 |
Why?
|
| Pain Measurement | 10 | 2019 | 477 | 0.440 |
Why?
|
| Arthroscopy | 9 | 2019 | 1053 | 0.440 |
Why?
|
| Information Seeking Behavior | 1 | 2013 | 6 | 0.440 |
Why?
|
| Proprioception | 2 | 2011 | 20 | 0.430 |
Why?
|
| Point-of-Care Systems | 2 | 2013 | 58 | 0.430 |
Why?
|
| Venous Thromboembolism | 1 | 2014 | 35 | 0.420 |
Why?
|
| Polyethylene | 8 | 2023 | 124 | 0.420 |
Why?
|
| Prospective Studies | 12 | 2014 | 1771 | 0.410 |
Why?
|
| Joint Capsule | 5 | 2007 | 56 | 0.410 |
Why?
|
| Patella | 4 | 2015 | 69 | 0.400 |
Why?
|
| Decision Making | 2 | 2017 | 221 | 0.400 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2013 | 111 | 0.400 |
Why?
|
| Inpatients | 3 | 2019 | 125 | 0.400 |
Why?
|
| Scaphoid Bone | 5 | 2007 | 22 | 0.400 |
Why?
|
| Patient Satisfaction | 8 | 2009 | 313 | 0.390 |
Why?
|
| Patient Selection | 6 | 2016 | 192 | 0.390 |
Why?
|
| Hand Strength | 10 | 2019 | 58 | 0.380 |
Why?
|
| Physical Examination | 3 | 2010 | 109 | 0.370 |
Why?
|
| Radius | 8 | 2012 | 33 | 0.360 |
Why?
|
| Adolescent | 14 | 2020 | 2156 | 0.360 |
Why?
|
| Postoperative Care | 5 | 2019 | 134 | 0.360 |
Why?
|
| Movement | 3 | 2007 | 111 | 0.350 |
Why?
|
| Denervation | 2 | 2018 | 21 | 0.340 |
Why?
|
| Young Adult | 10 | 2020 | 1984 | 0.340 |
Why?
|
| Arthrometry, Articular | 1 | 2010 | 13 | 0.340 |
Why?
|
| Quality Improvement | 3 | 2016 | 138 | 0.330 |
Why?
|
| Critical Pathways | 2 | 2007 | 19 | 0.330 |
Why?
|
| Osteotomy | 5 | 2014 | 165 | 0.330 |
Why?
|
| Trapezium Bone | 1 | 2009 | 1 | 0.320 |
Why?
|
| Time Factors | 10 | 2018 | 1429 | 0.310 |
Why?
|
| Anesthesia | 1 | 2009 | 29 | 0.310 |
Why?
|
| Algorithms | 2 | 2010 | 348 | 0.310 |
Why?
|
| Ambulatory Care | 1 | 2009 | 69 | 0.300 |
Why?
|
| Prostheses and Implants | 1 | 2010 | 151 | 0.300 |
Why?
|
| Prosthesis Implantation | 1 | 2008 | 25 | 0.300 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2007 | 23 | 0.300 |
Why?
|
| Models, Biological | 1 | 2010 | 321 | 0.300 |
Why?
|
| Acetabulum | 7 | 2013 | 229 | 0.280 |
Why?
|
| Lactones | 1 | 2007 | 9 | 0.280 |
Why?
|
| Sulfones | 1 | 2007 | 20 | 0.280 |
Why?
|
| Radius Fractures | 3 | 2014 | 26 | 0.280 |
Why?
|
| Ossification, Heterotopic | 1 | 2007 | 35 | 0.280 |
Why?
|
| Surveys and Questionnaires | 6 | 2019 | 1140 | 0.270 |
Why?
|
| Hospitals | 2 | 2019 | 168 | 0.270 |
Why?
|
| Lunate Bone | 5 | 2007 | 6 | 0.270 |
Why?
|
| Physicians | 3 | 2018 | 120 | 0.270 |
Why?
|
| Fractures, Ununited | 2 | 2007 | 15 | 0.260 |
Why?
|
| Femoral Fractures | 2 | 2019 | 34 | 0.260 |
Why?
|
| Risk Factors | 6 | 2019 | 2295 | 0.260 |
Why?
|
| Sensitivity and Specificity | 7 | 2013 | 479 | 0.260 |
Why?
|
| Periprosthetic Fractures | 2 | 2019 | 26 | 0.260 |
Why?
|
| Osteoma, Osteoid | 1 | 2006 | 2 | 0.260 |
Why?
|
| Finger Phalanges | 1 | 2006 | 2 | 0.260 |
Why?
|
| Feasibility Studies | 4 | 2013 | 219 | 0.260 |
Why?
|
| Arthritis | 3 | 2019 | 51 | 0.250 |
Why?
|
| Factor IXa | 2 | 2015 | 2 | 0.250 |
Why?
|
| Risk | 2 | 2023 | 203 | 0.240 |
Why?
|
| Self Care | 1 | 2006 | 89 | 0.240 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2006 | 77 | 0.230 |
Why?
|
| Certification | 2 | 2015 | 24 | 0.230 |
Why?
|
| Hip Joint | 6 | 2014 | 544 | 0.230 |
Why?
|
| Nerve Endings | 3 | 2011 | 4 | 0.230 |
Why?
|
| Bone Neoplasms | 1 | 2006 | 130 | 0.230 |
Why?
|
| Bone Transplantation | 2 | 2005 | 198 | 0.220 |
Why?
|
| Clinical Competence | 3 | 2017 | 205 | 0.210 |
Why?
|
| Osteoarthritis | 3 | 2018 | 324 | 0.210 |
Why?
|
| Stress, Psychological | 1 | 2005 | 235 | 0.210 |
Why?
|
| Iatrogenic Disease | 1 | 2023 | 25 | 0.210 |
Why?
|
| Hand Injuries | 1 | 2003 | 11 | 0.210 |
Why?
|
| Pain, Intractable | 1 | 2002 | 9 | 0.200 |
Why?
|
| Rotation | 5 | 2010 | 135 | 0.200 |
Why?
|
| Contraindications | 3 | 2012 | 31 | 0.190 |
Why?
|
| United States | 5 | 2017 | 2034 | 0.190 |
Why?
|
| Molecular Structure | 3 | 2015 | 16 | 0.190 |
Why?
|
| Postoperative Period | 4 | 2019 | 331 | 0.180 |
Why?
|
| Pronation | 6 | 2007 | 10 | 0.180 |
Why?
|
| Supination | 6 | 2007 | 18 | 0.180 |
Why?
|
| Incidence | 3 | 2018 | 758 | 0.180 |
Why?
|
| Intraoperative Care | 1 | 2021 | 41 | 0.180 |
Why?
|
| Length of Stay | 3 | 2013 | 315 | 0.180 |
Why?
|
| Chronic Disease | 3 | 2010 | 413 | 0.180 |
Why?
|
| Posture | 2 | 2019 | 62 | 0.170 |
Why?
|
| Focus Groups | 3 | 2015 | 87 | 0.160 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 673 | 0.160 |
Why?
|
| Office Visits | 1 | 2019 | 11 | 0.160 |
Why?
|
| Cadaver | 8 | 2011 | 367 | 0.150 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 877 | 0.150 |
Why?
|
| Educational Technology | 1 | 2018 | 1 | 0.150 |
Why?
|
| Education, Distance | 1 | 2018 | 16 | 0.140 |
Why?
|
| Finger Joint | 2 | 2011 | 5 | 0.140 |
Why?
|
| Surgeons | 1 | 2019 | 86 | 0.140 |
Why?
|
| Child | 4 | 2020 | 1290 | 0.140 |
Why?
|
| Simulation Training | 1 | 2018 | 38 | 0.140 |
Why?
|
| Weight-Bearing | 4 | 2006 | 156 | 0.140 |
Why?
|
| Dinoprostone | 2 | 2007 | 17 | 0.140 |
Why?
|
| Probability | 4 | 2004 | 87 | 0.130 |
Why?
|
| Muscle, Skeletal | 4 | 2010 | 375 | 0.130 |
Why?
|
| Health Status Indicators | 2 | 2008 | 71 | 0.130 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2007 | 163 | 0.130 |
Why?
|
| Body Mass Index | 3 | 2015 | 457 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2007 | 195 | 0.130 |
Why?
|
| Hand Bones | 1 | 2015 | 1 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 326 | 0.120 |
Why?
|
| Patient Care Planning | 1 | 2016 | 37 | 0.120 |
Why?
|
| Sampling Studies | 2 | 2013 | 29 | 0.120 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2015 | 14 | 0.120 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 37 | 0.120 |
Why?
|
| Ceramics | 1 | 2015 | 21 | 0.120 |
Why?
|
| Drug Design | 1 | 2015 | 22 | 0.120 |
Why?
|
| Educational Measurement | 2 | 2014 | 57 | 0.120 |
Why?
|
| Dissection | 3 | 2011 | 25 | 0.120 |
Why?
|
| Foreign-Body Reaction | 1 | 2015 | 26 | 0.120 |
Why?
|
| Tendon Injuries | 3 | 2007 | 198 | 0.120 |
Why?
|
| Comorbidity | 1 | 2016 | 479 | 0.120 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 114 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2016 | 345 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 255 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 333 | 0.120 |
Why?
|
| Education, Continuing | 1 | 2014 | 11 | 0.120 |
Why?
|
| Anticoagulants | 1 | 2015 | 87 | 0.110 |
Why?
|
| Dermatologic Surgical Procedures | 2 | 2004 | 11 | 0.110 |
Why?
|
| Disability Evaluation | 2 | 2006 | 263 | 0.110 |
Why?
|
| Osteoporotic Fractures | 1 | 2014 | 12 | 0.110 |
Why?
|
| Equipment Failure Analysis | 2 | 2005 | 98 | 0.110 |
Why?
|
| Fluoroscopy | 2 | 2004 | 48 | 0.110 |
Why?
|
| Family Practice | 1 | 2013 | 15 | 0.110 |
Why?
|
| Elective Surgical Procedures | 1 | 2014 | 37 | 0.110 |
Why?
|
| Allografts | 1 | 2015 | 211 | 0.110 |
Why?
|
| Education, Medical | 1 | 2013 | 45 | 0.110 |
Why?
|
| Joint Dislocations | 2 | 2011 | 56 | 0.100 |
Why?
|
| Disease Progression | 2 | 2006 | 673 | 0.100 |
Why?
|
| Cohort Studies | 4 | 2012 | 1882 | 0.100 |
Why?
|
| Mechanoreceptors | 3 | 2011 | 7 | 0.100 |
Why?
|
| Osteoporosis | 1 | 2014 | 77 | 0.100 |
Why?
|
| Arthroplasty | 2 | 2004 | 143 | 0.100 |
Why?
|
| Risk Assessment | 4 | 2012 | 626 | 0.100 |
Why?
|
| Mass Screening | 1 | 2014 | 168 | 0.100 |
Why?
|
| Accreditation | 1 | 2012 | 14 | 0.100 |
Why?
|
| Kinesthesis | 1 | 2011 | 2 | 0.100 |
Why?
|
| Muscle Denervation | 1 | 2011 | 3 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2011 | 31 | 0.090 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2011 | 4 | 0.090 |
Why?
|
| Industry | 1 | 2011 | 5 | 0.090 |
Why?
|
| Fracture Fixation, Internal | 2 | 2019 | 59 | 0.090 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 55 | 0.090 |
Why?
|
| Braces | 1 | 2010 | 23 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2011 | 55 | 0.090 |
Why?
|
| Medical History Taking | 1 | 2010 | 30 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2012 | 683 | 0.090 |
Why?
|
| Osteonecrosis | 2 | 2013 | 16 | 0.090 |
Why?
|
| Posterior Cruciate Ligament | 1 | 2010 | 23 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 74 | 0.080 |
Why?
|
| Free Tissue Flaps | 1 | 2010 | 15 | 0.080 |
Why?
|
| Prosthesis Fitting | 1 | 2010 | 21 | 0.080 |
Why?
|
| Logistic Models | 2 | 2014 | 395 | 0.080 |
Why?
|
| Torque | 2 | 2007 | 22 | 0.080 |
Why?
|
| Orthopedics | 1 | 2011 | 108 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2007 | 170 | 0.080 |
Why?
|
| Bone Cements | 2 | 2009 | 88 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2010 | 194 | 0.080 |
Why?
|
| Cementation | 2 | 2010 | 33 | 0.080 |
Why?
|
| Fractures, Malunited | 1 | 2008 | 4 | 0.080 |
Why?
|
| Blood Sedimentation | 3 | 2015 | 53 | 0.080 |
Why?
|
| Orthotic Devices | 1 | 2008 | 24 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2019 | 175 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 138 | 0.070 |
Why?
|
| Hip Fractures | 1 | 2008 | 26 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2007 | 55 | 0.070 |
Why?
|
| Operative Time | 2 | 2021 | 91 | 0.070 |
Why?
|
| Tomography, Spiral Computed | 1 | 2007 | 25 | 0.070 |
Why?
|
| Osseointegration | 2 | 2008 | 67 | 0.070 |
Why?
|
| Phantoms, Imaging | 1 | 2007 | 33 | 0.070 |
Why?
|
| Osteoarthritis, Hip | 2 | 2010 | 106 | 0.070 |
Why?
|
| Linear Models | 1 | 2008 | 248 | 0.070 |
Why?
|
| Analgesia, Epidural | 1 | 2007 | 54 | 0.070 |
Why?
|
| Positron-Emission Tomography | 1 | 2007 | 87 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2007 | 27 | 0.070 |
Why?
|
| Tenodesis | 1 | 2010 | 168 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 158 | 0.070 |
Why?
|
| Gait | 1 | 2010 | 412 | 0.070 |
Why?
|
| Fracture Healing | 2 | 2008 | 32 | 0.070 |
Why?
|
| Sex Factors | 2 | 2005 | 461 | 0.070 |
Why?
|
| Gadolinium | 1 | 2006 | 6 | 0.060 |
Why?
|
| Curettage | 1 | 2006 | 9 | 0.060 |
Why?
|
| Interleukins | 1 | 2006 | 23 | 0.060 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 2006 | 3 | 0.060 |
Why?
|
| Urinary Bladder Diseases | 1 | 2006 | 7 | 0.060 |
Why?
|
| Supine Position | 1 | 2006 | 21 | 0.060 |
Why?
|
| Membranes | 1 | 2005 | 9 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2006 | 55 | 0.060 |
Why?
|
| Contrast Media | 1 | 2006 | 66 | 0.060 |
Why?
|
| Health Surveys | 1 | 2006 | 86 | 0.060 |
Why?
|
| Trauma Severity Indices | 2 | 2002 | 10 | 0.060 |
Why?
|
| Age Factors | 2 | 2005 | 759 | 0.060 |
Why?
|
| Metacarpophalangeal Joint | 1 | 2005 | 5 | 0.060 |
Why?
|
| Porosity | 2 | 2021 | 60 | 0.060 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2008 | 259 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2006 | 130 | 0.060 |
Why?
|
| Early Ambulation | 1 | 2004 | 17 | 0.060 |
Why?
|
| Physical Education and Training | 1 | 2004 | 5 | 0.060 |
Why?
|
| Running | 1 | 2004 | 14 | 0.060 |
Why?
|
| Oxygen Consumption | 1 | 2004 | 50 | 0.060 |
Why?
|
| Arthrodesis | 1 | 2005 | 39 | 0.060 |
Why?
|
| C-Reactive Protein | 3 | 2014 | 96 | 0.060 |
Why?
|
| Acute-Phase Reaction | 1 | 2004 | 4 | 0.060 |
Why?
|
| Leucine | 1 | 2004 | 10 | 0.060 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2004 | 3 | 0.060 |
Why?
|
| Physical Therapy Modalities | 1 | 2004 | 71 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2004 | 256 | 0.060 |
Why?
|
| Heart Rate | 1 | 2004 | 113 | 0.060 |
Why?
|
| Esthetics | 1 | 2004 | 13 | 0.060 |
Why?
|
| Synovial Cyst | 1 | 2004 | 3 | 0.060 |
Why?
|
| Surgical Instruments | 1 | 2004 | 25 | 0.050 |
Why?
|
| Corrosion | 2 | 2015 | 126 | 0.050 |
Why?
|
| Intraoperative Complications | 1 | 2004 | 63 | 0.050 |
Why?
|
| Chromium | 2 | 2015 | 87 | 0.050 |
Why?
|
| Cobalt | 2 | 2015 | 110 | 0.050 |
Why?
|
| Joints | 1 | 2003 | 68 | 0.050 |
Why?
|
| Amputation, Traumatic | 1 | 2003 | 3 | 0.050 |
Why?
|
| Thumb | 1 | 2003 | 5 | 0.050 |
Why?
|
| Titanium | 2 | 2015 | 172 | 0.050 |
Why?
|
| Fingers | 1 | 2003 | 10 | 0.050 |
Why?
|
| Tendon Transfer | 1 | 2003 | 17 | 0.050 |
Why?
|
| Equipment Failure | 1 | 2002 | 37 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2020 | 639 | 0.050 |
Why?
|
| ROC Curve | 2 | 2014 | 141 | 0.050 |
Why?
|
| Fracture Fixation | 1 | 2002 | 20 | 0.050 |
Why?
|
| Survivorship | 1 | 2022 | 23 | 0.050 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 595 | 0.050 |
Why?
|
| Osteolysis | 2 | 2015 | 139 | 0.050 |
Why?
|
| Microscopy, Confocal | 3 | 2007 | 88 | 0.050 |
Why?
|
| Nerve Block | 1 | 2002 | 65 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 474 | 0.050 |
Why?
|
| Palliative Care | 1 | 2002 | 110 | 0.050 |
Why?
|
| Bone Malalignment | 1 | 2021 | 20 | 0.050 |
Why?
|
| Leukocyte Count | 2 | 2014 | 61 | 0.050 |
Why?
|
| Quality of Life | 1 | 2006 | 627 | 0.040 |
Why?
|
| Synovial Fluid | 2 | 2014 | 92 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2012 | 587 | 0.040 |
Why?
|
| Femur Head | 1 | 2019 | 69 | 0.040 |
Why?
|
| Tendinopathy | 1 | 2019 | 51 | 0.040 |
Why?
|
| Brain | 1 | 2007 | 1649 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2019 | 268 | 0.040 |
Why?
|
| Surgical Wound | 1 | 2018 | 9 | 0.040 |
Why?
|
| Pain | 1 | 2021 | 406 | 0.040 |
Why?
|
| Drainage | 1 | 2018 | 39 | 0.040 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2010 | 41 | 0.040 |
Why?
|
| Wound Healing | 1 | 2018 | 148 | 0.030 |
Why?
|
| Registries | 1 | 2018 | 188 | 0.030 |
Why?
|
| Device Removal | 2 | 2009 | 84 | 0.030 |
Why?
|
| Hydrazines | 2 | 2007 | 7 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2015 | 32 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 10 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 118 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2015 | 108 | 0.030 |
Why?
|
| Binding Sites | 1 | 2015 | 73 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2015 | 70 | 0.030 |
Why?
|
| Grounded Theory | 1 | 2015 | 4 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2006 | 74 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2015 | 80 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 499 | 0.030 |
Why?
|
| Patellar Ligament | 1 | 2015 | 41 | 0.030 |
Why?
|
| Patient Care | 1 | 2015 | 30 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2014 | 56 | 0.030 |
Why?
|
| Disease Management | 1 | 2015 | 102 | 0.030 |
Why?
|
| Metals | 1 | 2015 | 140 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2014 | 121 | 0.030 |
Why?
|
| Transplantation, Homologous | 2 | 2005 | 267 | 0.030 |
Why?
|
| Information Science | 1 | 2013 | 1 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2014 | 63 | 0.030 |
Why?
|
| Program Development | 1 | 2014 | 50 | 0.030 |
Why?
|
| Knowledge | 1 | 2013 | 17 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 57 | 0.030 |
Why?
|
| Cytokines | 2 | 2006 | 221 | 0.030 |
Why?
|
| Rats | 1 | 2015 | 661 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2014 | 84 | 0.030 |
Why?
|
| Health Personnel | 1 | 2014 | 94 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2004 | 256 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 131 | 0.030 |
Why?
|
| Anthropometry | 1 | 2012 | 34 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2013 | 82 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 124 | 0.020 |
Why?
|
| Torsion Abnormality | 1 | 2012 | 1 | 0.020 |
Why?
|
| Injury Severity Score | 1 | 2011 | 9 | 0.020 |
Why?
|
| Lidocaine | 1 | 2011 | 21 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 2011 | 35 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2011 | 47 | 0.020 |
Why?
|
| Training Support | 1 | 2011 | 4 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 2011 | 14 | 0.020 |
Why?
|
| Conflict of Interest | 1 | 2011 | 12 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 185 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 57 | 0.020 |
Why?
|
| Biomarkers | 1 | 2014 | 561 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 441 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2011 | 404 | 0.020 |
Why?
|
| Polymethacrylic Acids | 1 | 2010 | 5 | 0.020 |
Why?
|
| Illinois | 1 | 2010 | 250 | 0.020 |
Why?
|
| Patellofemoral Joint | 1 | 2010 | 64 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 161 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 260 | 0.020 |
Why?
|
| Artifacts | 1 | 2007 | 30 | 0.020 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2007 | 30 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 3627 | 0.020 |
Why?
|
| Observer Variation | 1 | 2007 | 93 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2007 | 35 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2007 | 151 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2006 | 7 | 0.020 |
Why?
|
| Lasers | 1 | 2006 | 17 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 36 | 0.020 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2008 | 119 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2006 | 17 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2008 | 162 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2006 | 48 | 0.020 |
Why?
|
| Walking | 1 | 2008 | 253 | 0.020 |
Why?
|
| Malawi | 1 | 2004 | 2 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 2004 | 2 | 0.010 |
Why?
|
| Rupture | 1 | 2004 | 102 | 0.010 |
Why?
|
| Acute-Phase Proteins | 1 | 2004 | 10 | 0.010 |
Why?
|
| Exercise Test | 1 | 2004 | 118 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 176 | 0.010 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2003 | 4 | 0.010 |
Why?
|
| Bone Wires | 1 | 2003 | 10 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 2003 | 49 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 299 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 306 | 0.010 |
Why?
|
| Infant | 1 | 2004 | 564 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2002 | 154 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 338 | 0.010 |
Why?
|